000 | 01552 a2200433 4500 | ||
---|---|---|---|
005 | 20250513143942.0 | ||
264 | 0 | _c19980625 | |
008 | 199806s 0 0 eng d | ||
022 | _a0741-5400 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSpiecker, M | |
245 | 0 | 0 |
_aDifferential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. _h[electronic resource] |
260 |
_bJournal of leukocyte biology _cJun 1998 |
||
300 |
_a732-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 |
_aCell Adhesion Molecules _xbiosynthesis |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
650 | 0 | 4 |
_aE-Selectin _xbiosynthesis |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aI-kappa B Kinase |
650 | 0 | 4 | _aI-kappa B Proteins |
650 | 0 | 4 |
_aIntercellular Adhesion Molecule-1 _xbiosynthesis |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aNF-KappaB Inhibitor alpha |
650 | 0 | 4 |
_aNF-kappa B _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide _xpharmacology |
650 | 0 | 4 | _aPromoter Regions, Genetic |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
650 | 0 | 4 |
_aVascular Cell Adhesion Molecule-1 _xbiosynthesis |
700 | 1 | _aDarius, H | |
700 | 1 | _aKaboth, K | |
700 | 1 | _aHübner, F | |
700 | 1 | _aLiao, J K | |
773 | 0 |
_tJournal of leukocyte biology _gvol. 63 _gno. 6 _gp. 732-9 |
|
999 |
_c9587083 _d9587083 |